Indications and Usage for B-12 Compliance Injection Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see DRUG INTERACTION), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
**Lot certified by HPLC certificate of analysis exceeding 99%, mass spectrometry confirming theoretical molecular weight (BPC-157: 1419.53 Da / TB-500 fragment: supplier-dependent, full thymosin beta-4: 4963 Da), cold chain maintained from synthesis to delivery.** Unique dual-lyophilized vial, two-minute reconstitution, aliquoting supported to extend functional shelf life
Weeks 7-12: Sustained Response The 7-12 week period represents the timeframe used in the most successful clinical trials
BPC-157 vials should be reconstituted with bacteriostatic water for laboratory administration
We work with you to determine the optimal dosage and delivery method for your specific situation, ensuring that your BPC-157 therapy aligns perfectly with your wellness goals
Intervention study While the studies cited above are largely consistent with the existence of a high-folatelow-vitamin B-12 interaction affecting both tHcy and MMA metabolism, data are limited on the effect of high-dose folic acid supplements on these 2 biomarkers in vitamin B-12deficient individuals
